Back to catalogue
№ 052 20 filings · 2021-10-29 → 2026-08-27

ARROW EXPLORATION CORP.

AXL
Energy Share price 37.00p Market cap £106m Overall fit 260 /1000

Fundamentally solid junior E&P with net cash, real growth and a cheap-ish multiple, but essentially zero AI-receiver exposure and commodity-price operating leverage rather than platform scale leverage — largely outside the strategy despite the attractive standalone risk/reward.

Fair value range 33p–50p Mid case · £120m
Absolute upside +13.5% vs current market cap
Conviction 3/5 confidence in fair call
Supports the call
  • Detailed IFRS disclosure and reserve reports across the period
  • Multiple valuation methods converge (EV/EBITDA ~3x, ~35% of 2P NPV10) on a 30-50p range
  • Consistent operational delivery since 2023
Limits the call
  • Fair value highly sensitive to Brent assumption (+/-40% EBITDA on $60 vs $85)
  • Tapir block interest contingent on Ecopetrol consent — hard-to-quantify structural discount
Methodology

Blended EV/EBITDA and risked 2P NAV

In one line · bull case

Cash-generating Colombian light-oil junior at ~1.5x forward EBITDA with net cash, real drilling-led growth and a fresh Icaco discovery.

In one line · biggest risk

Formal Ecopetrol assignment of the Tapir block interest has been outstanding for eight years and adverse resolution would impair the core asset.

Drivers
AI beneficiary 5 /100
Pure Colombian light-oil producer with no exposure to AI value chains; long-term substitution risk if anything.
Operating leverage 45 /100
Real price-driven leverage (netback $27→$63/boe on Brent move) but not durable platform/fixed-cost scale.
Earnings vs expectations 68 /100
Consistent quarter-on-quarter growth and management commentary broadly delivered over 2024-26.
Growth momentum 82 /100
Q2 2026 revenue +116% YoY, production +30% YoY; Icaco discovery adds runway.
Moat 22 /100
No competitive moat; Tapir interest still contingent on Ecopetrol consent — structural risk.
Earnings quality 65 /100
Clean IFRS with prior impairments; decent cash conversion (H1 op cash $29m vs $39m EBITDA).
Management quality 65 /100
Delivered production growth and made accretive Thorsby M&A; conservative on debt.
Cyclicality 85 /100
Deeply cyclical Brent-linked producer; earnings swing 3x on a 40% price move.
Leverage 8 /100
Net cash of $28.5m, no debt, $20m undrawn revolver; fortress balance sheet.
Value-trap signals · 4
  • Tapir block interest contingent on Ecopetrol consent since 2018
  • Colombian oil fiscal/royalty regime subject to political change
  • Related-party loans to executives/directors ($742k)
  • Ombu/Capella shut in with $10.5m prior impairment

ARROW EXPLORATION CORP. (AXL) — Investment Research Note

Executive summary

Arrow Exploration is a Colombian-focused junior oil producer (secondary Alberta gas) operating four Llanos and MMV basin blocks (Tapir, Oso Pardo, Ombu, plus recently-added Thorsby in Alberta), with 50% of production from the Tapir block sold at Brent-linked prices. Production has scaled from ~470 boe/d in FY 2020 to 4,902 boe/d in Q2 2026 on the back of successful drilling at Rio Cravo Este, Carrizales Norte and — most recently — the Icaco discovery, while the balance sheet has moved from net debt to $28.5m cash with no borrowings. The single most important point for valuation today is that H1 2026 EBITDA of $39.2m annualises to a run-rate that leaves the £84.6m market cap trading at ~2x forward EV/EBITDA — cheap on multiples but heavily exposed to Brent, Colombian country risk and the still-informal Tapir block assignment from Ecopetrol.

Fair value estimate

  • Fair value range: 33p – 50p per share (mid ~42p)
  • Implied market cap: £94m – £143m (mid ~£120m)

Methodology: Blended EV/EBITDA on run-rate cash generation and a check against risked 2P NAV.

Key assumptions:

  • 2026E production ~5,000 boe/d; H1 2026 EBITDA $39.2m, full year plausibly $55–65m at $80–90 Brent, or ~$35–45m at a normalized $70 Brent case 2026-08 Q2 results
  • EV/EBITDA of 2.5–3.5x (typical range for AIM-listed emerging market juniors); mid = 3.0x
  • Net cash bridge: $28.5m cash + $14.5m working capital = ~$43m of surplus liquidity 2026-08 Q2 results
  • Year-end 2023 2P NPV10 pre-tax was US$280m; H1 2026 Icaco discovery and Thorsby acquisition (Thorsby 2P NPV10 $51m USD) plausibly grow 2P NAV to $350–400m 2024-04 annual; 2026-08 Thorsby press release; at a 30–40% risking factor (Colombia country + Ecopetrol consent overhang), that supports $105–160m fair EV

At current £84.6m (~$107m USD) and ~$63m EV net of cash and WC, the shares trade at ~1.4x forward EBITDA and ~17% of 2P NPV10 — genuinely cheap on the numbers, but with real fundamental discounts embedded. My midpoint of ~42p implies ~42% upside to the current 29.6p; the low end of my range (33p) is essentially in-line.

Sector context

  • Sector: Energy / Oil & Gas E&P (junior). ICB Industry classification confirmed.
  • Quality/growth/leverage profile: Above-average on balance sheet (net cash vs. peers typically levered), above-average on production growth (30% YoY Q2 2026), below-average on scale and geographic diversification. Netbacks of $63/boe are strong thanks to Brent linkage and low Colombian royalties.
  • Listed peer set for reference: Serica Energy (SQZ), Enquest (ENQ), Gran Tierra Energy (GTE), Frontera Energy (FEC). Arrow is smaller than all of these but the Gran Tierra / Frontera Colombian oil comparison is most directly relevant.

Investment thesis (3 bullets)

  • Self-funded, cash-generating growth in Colombian light oil. Q2 2026 revenue of $34.2m and adjusted EBITDA of $25.1m against just $9.4m of Q2 capex demonstrates the company is funding a full drilling programme from cash flow with $28.5m cash to spare and zero debt 2026-08 Q2 results. This removes the funding-risk overhang that normally caps AIM junior valuations.
  • Icaco discovery + Mateguafa Attic build-out extend the runway. The Icaco field ramped from zero to 188 boe/d net in Q2 2026 and management describes it as "a major production platform" with multi-formation potential 2026-08 Q2 results. Mateguafa contributed 2,228 boe/d in Q2 2026 from a standing start a year earlier. Together they replace declines at Rio Cravo Este and Carrizales Norte.
  • Cheap on cash multiples with net cash balance sheet. At £84.6m market cap versus $28.5m cash / no debt and $39.2m of H1 2026 EBITDA, EV/annualised EBITDA is ~1.5x. Even discounting for lower normalised Brent, the multiple is well below sector norms and shares have re-rated 119% in the past 12 months as the market has begun to recognise this market data 2026-09.

Key risks (3 bullets)

  • Tapir block interest is still contingent on Ecopetrol's consent. Arrow's 50% economic interest in Tapir — the source of virtually all its production growth — is held through a private contract with Petrolco and formal assignment to Arrow has not yet been approved by Ecopetrol; the licence extension is also still in "constructive engagement" phase 2026-08 Q2 results, and consistent language in every filing since 2021. Adverse resolution could impair the core asset.
  • Brent-price sensitivity and Colombian fiscal risk. With realized crude prices of $91/bbl in Q2 2026 vs $57/bbl in Q2 2025, EBITDA more than tripled — the operating leverage cuts both ways. Colombia has already introduced a surcharge on oil producers (tax rate reached 45% in 2023) and the Petro government has periodically signalled further changes 2023 annual report, tax notes.
  • Impairment history flags the fragility of individual CGUs. FY 2025 recorded $7.6m of impairments: $5.9m at Santa Isabel (Oso Pardo) on reserve revisions and lower price decks, and $1.8m at KEHO after unsuccessful drilling 2025-11 Q3 2025 note 7. Ombu/Capella has been shut in since early 2023. Sub-CGU impairment risk remains real if commodity prices soften or exploration disappoints.

Operating leverage

Arrow displays classic commodity operating leverage rather than fixed-cost / platform leverage. Q2 2025 operating cost was $19.79/boe against Q2 2026 of $15.05/boe (economies of scale on higher volume), while realised prices rose from $53/boe to $89/boe — the netback ballooned from $27.36 to $63.42 per boe. On a 30% production increase and 68% price increase, EBITDA quadrupled from $6.3m to $25.1m 2026-08 Q2 results. G&A is largely fixed at ~$3.2m/quarter, so incremental production drops disproportionately to profit — a 10-20% volume beat at current prices would plausibly add ~$8-12m to annual EBITDA. However, this is not the durable subscription/scale leverage the strategy seeks — it is price leverage, and it reverses when Brent falls. There are no network effects, no capacity-constrained pricing power, no fixed-cost SaaS trajectory.

Value-trap signals

  • Contingent title on the core asset (Ecopetrol consent for Tapir has been outstanding since 2018) — a structural not temporary discount.
  • Country/regulatory risk in Colombia — royalty deductibility and oil surcharges are subject to political change.
  • Related-party loans to executives and directors ($742k receivable at June 2026, disclosed in note 4) — small but a governance amber.
  • Ombu/Capella suspended since early 2023 with $10.5m impairment taken; a chunk of prior reserve base is effectively parked.

Overall these look like a legitimate structural discount to fair NAV rather than a value trap in the classic sense — the business is growing and cash-generating.

Earnings vs. expectations

Arrow does not publish formal guidance or have material sell-side coverage on the AIM ticker, so the "expectations" bar is largely qualitative management commentary from prior filings. Where I can compare:

  • Q4 2025 → Q1 2026 → Q2 2026: management guided to "another year of production growth" for FY 2026; actual Q2 4,902 boe/d vs Q2 2025 3,768 boe/d clearly delivers on that promise.
  • Icaco: management flagged in Q1 2026 that discovery could "have material impact on the Company"; Q2 2026 already contributing 188 boe/d net with more wells drilling — early-stage delivery on track.
  • Rio Cravo Este / Alberta Llanos: production has declined faster than guided (RCE from 1,178 boe/d in Q4 2025 to 753 boe/d in Q2 2026) — a modest disappointment offset by other fields.

Summary pattern: mostly beat or meet on production and headline financials over the past six quarters, with pockets of underperformance on individual field decline rates. Consistent execution overall.

Conviction

Conviction: 3 (moderate).

Anchors:

  • Well-disclosed IFRS financials with detailed CGU-level reporting and reserve reports.
  • Simple business model (E&P) with observable netback economics.
  • Multiple valuation methods (EV/EBITDA, EV/boe/d, % of NAV) converge on a fair value in the 30–50p range.

Caveats:

  • Brent price assumption drives the fair value range disproportionately — Brent at $60 vs $85 shifts EBITDA by ~40%.
  • Tapir contingent title and Colombian fiscal environment are hard-to-quantify overhangs I have applied as a blunt haircut.

Part 2: Structured JSON

Filings consulted · 21

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-08-27Arrow Announces Q2 2026 Interim Results2026-08-27_9742126_arrow-announces-q2-2026-interim-results.md0.90
  2. 2026-08-14Arrow Announces Alberta Property Acquisition2026-08-14_9721536_arrow-announces-alberta-property-acquisition.md0.75
  3. 2026-05-27Arrow Announces Q1 2026 Interim Results2026-05-27_9586463_arrow-announces-q1-2026-interim-results.md0.90
  4. 2026-05-22Investor Presentation Via Investor Meet Company2026-05-22_9581366_investor-presentation-via-investor-meet-company.md0.70
  5. 2025-11-27Arrow Announces Q3 2025 Interim Results2025-11-27_9259966_arrow-announces-q3-2025-interim-results.md0.77
  6. 2025-08-28Arrow Announces Q2 2025 Interim Results2025-08-28_9076528_arrow-announces-q2-2025-interim-results.md0.58
  7. 2025-05-30Q1 2025 Interim Results And Operational Update2025-05-30_8903856_q1-2025-interim-results-and-operational-update.md0.58
  8. 2024-11-28Q3 2024 Interim Results2024-11-28_8577201_q3-2024-interim-results.md0.58
  9. 2024-06-04Replacement Q1 2024 Interim Results2024-06-04_8240029_replacement-q1-2024-interim-results.md0.41
  10. 2024-05-30Q1 2024 Interim Results2024-05-30_8230104_q1-2024-interim-results.md0.41
  11. 2024-04-292023 Annual Results MD Amp A And Reserves Report2024-04-29_8160694_2023-annual-results-md-amp-a-and-reserves-report.md0.45
  12. 2023-11-29Q3 2023 Interim Results2023-11-29_7908873_q3-2023-interim-results.md0.41
  13. 2023-09-21Result OF Agm2023-09-21_7768529_result-of-agm.md0.14
  14. 2023-08-29Arrow Announces Q2 2023 Interim Results2023-08-29_7721130_arrow-announces-q2-2023-interim-results.md0.23
  15. 2023-05-30Q1 2023 Interim Results2023-05-30_7549114_q1-2023-interim-results.md0.23
  16. 2023-05-022022 Annual Results MD Amp A And Reserves Report2023-05-02_7507455_2022-annual-results-md-amp-a-and-reserves-report.md0.25
  17. 2022-05-18Notice OF Agm2022-05-18_6930920_notice-of-agm.md0.07
  18. 2022-04-262021 Annual Results MD Amp A And Reserves Report2022-04-26_7041716_2021-annual-results-md-amp-a-and-reserves-report.md0.25
  19. 2021-11-25Replacement 3rd Quarter Interim Results2021-11-25_6638970_replacement-3rd-quarter-interim-results.md0.23
  20. 2021-11-24Third Quarter Interim Results2021-11-24_6839306_third-quarter-interim-results.md0.23
  21. 2021-10-29Investor Presentation2021-10-29_6622344_investor-presentation.md0.17

This research note was authored by a large language model after reading 20 regulatory filings published between 2021-10-29 and 2026-08-27. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.